Ophthalmic Executives Provide Company Updates (Part 1 of 2)

As we think about innovation, we're very excited about what we're seeing across all of eye care at this point.

And we're seeing these themes emerge around connected patient care and driving greater efficiency in what we're doing within ophthalmology.

And for Alcon, one of the exciting things is the launch of Unity M, which will be a big presence on our booth here this year at the show, bringing new innovation to the microscope space, building on the launch of Unity VCS and CS that happened last year.

But Unity is not the whole story for us.

We're obviously excited about the things that we're doing on the IOL platform.

Last year we brought Clarion Panoptix Pro to the marketplace and this year we've launched Clarion True Plus, our entry into the monofocal plus space.

In retina, we're continuing to drive the launch of the Valeda PBM system, bringing new therapies for patients who are suffering from dry AMD.

And we're continuing the rollout of Voyager DSLT in the glaucoma space, which again makes it a lot easier to provide SLT therapy, which is very rapidly becoming frontline for glaucoma patients.

And so I think as you can see, a lot of the innovation, we're also trading on that theme of connected care and bringing greater efficiency into the clinic and to the OR setting for doctors and for patients.

And so excited about the next several days, excited to engage with the ophthalmology community, hear from them what's going well, but more importantly, hear where the unmet needs are still out there and where we can continue to innovate and bring a breakthrough for patients and for our surgeons.